Celldex May Have Best Efficacy In Chronic Spontaneous Urticaria

Sanofi Also Succeeds With BTKi In Phase II

 
• By Joseph Haas
Urticaria
Both Celldex and Sanofi hope to challenge Xolair in CSU • Source: Shutterstock

More from Clinical Trials

More from R&D